BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report
Published: December 2012 · Publisher: MarketLine
BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for BioMarin Pharmaceutical Inc.
- Intelligence on BioMarin Pharmaceutical Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 871 people as of January 21, 2011. The company recorded revenues of $376.3 million during the financial year (FY) ended December 2010, an increase of 15.9% over FY2009. The operating profit of the company was $0.5 million during FY2010, a decrease of 96.7% over FY2009. The net profit was $205.8 million in FY2010, as compared to a net loss of $0.5 million in FY2009.
Reasons to Purchase:
- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
Features:
- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for BioMarin Pharmaceutical Inc.
- Intelligence on BioMarin Pharmaceutical Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 871 people as of January 21, 2011. The company recorded revenues of $376.3 million during the financial year (FY) ended December 2010, an increase of 15.9% over FY2009. The operating profit of the company was $0.5 million during FY2010, a decrease of 96.7% over FY2009. The net profit was $205.8 million in FY2010, as compared to a net loss of $0.5 million in FY2009.
Reasons to Purchase:
- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2009 - 2013YTD*
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Top Financial Advisors
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
BioMarin Pharmaceutical Inc.: Corporate Venturing
BioMarin Pharmaceutical Inc.: Capital Raising
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Contracts
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2009 - 2013YTD*
Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 16: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Table 17: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 18: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 19: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 20: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 21: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 22: BioMarin Pharmaceutical Inc.: Contracts
Table 23: BioMarin Pharmaceutical Inc.: Financial Deals
Table 24: BioMarin Pharmaceutical Inc.: Financial Performance
Table 25: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
Table 26: BioMarin Pharmaceutical Inc.: Research & Development
Table 27: BioMarin Pharmaceutical Inc.: Strategy and Operations
List of Figures
Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 4: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 7: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 8: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Company History
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2009 - 2013YTD*
BioMarin Pharmaceutical Inc.: Advisors
BioMarin Pharmaceutical Inc.: Top Legal Advisors
BioMarin Pharmaceutical Inc.: Top Financial Advisors
BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
BioMarin Pharmaceutical Inc.: Corporate Venturing
BioMarin Pharmaceutical Inc.: Capital Raising
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Contracts
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2009 - 2013YTD*
Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 16: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Table 17: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 18: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 19: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 20: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 21: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 22: BioMarin Pharmaceutical Inc.: Contracts
Table 23: BioMarin Pharmaceutical Inc.: Financial Deals
Table 24: BioMarin Pharmaceutical Inc.: Financial Performance
Table 25: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
Table 26: BioMarin Pharmaceutical Inc.: Research & Development
Table 27: BioMarin Pharmaceutical Inc.: Strategy and Operations
List of Figures
Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 4: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 7: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 8: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.